Dissecting the regulatory mechanisms controlling inhibitory adenosine receptor signaling

Drug Development Research

Volumn 58, Issue 4, 2003, Pages 302-314

  Palmer, Timothy M ^a   Ferguson, Gail ^a   Watterson, Kenneth R ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Adenosine; cAMP; Desensitization; G protein; Purinergic receptors

Indexed keywords

ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR; CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; RECEPTOR SUBTYPE;

AGONIST; ANIMAL CELL; BIOCHEMISTRY; CONFERENCE PAPER; CONTROLLED STUDY; CYTOLOGY; DRUG RECEPTOR BINDING; HEART PROTECTION; ISCHEMIA; MOLECULAR BIOLOGY; NONHUMAN; PROTEIN PROTEIN INTERACTION; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TARGET CELL;

EID: 0038050674     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10185     Document Type: Conference Paper

References (74)

1. Ali H, Cunha-Melo JR, Saul WF, Beaven MA. 1990. Activation of phospholipase C via adenosine receptors provides synergistic signals for secretion in antigen-stimulated RBL-2H3 mast cells: evidence for a novel adenosine receptor. J Biol Chem 265:745-753.
2. Apgar JR. 1993. Polymerization of actin in RBL-2H3 cells can be triggered through either the IgE receptor or the adenosine receptor but different signaling pathways are used. Mol Biol Cell 5:313-322.
3. Baines CP, Zhang J, Wang G-W, Zheng Y-T, Xiu JX, Cardwell EM, Bolli R, Ping P. 2002. Mitochondrial PKCε and MAPK form signaling modules in the murine heart: enhanced mitochondrial. PKCε-MAPK interactions and differential MAPK activation in PKCε-induced cardioprotection. Circ Res 90:390-397.
4. Beard MB, O'Connell JC, Bolger GB, Houslay MD. 1999. The unique N-terminal domain of the cAMP phosphodiesterase PDE4D4 allows for interaction with specific SH3 domains. FEBS Lett 460:173-177.
5. Bockaert J, Pin JP. 1999. Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J 18:1723-1729.
6. Bohm SK, Grady EF, Bunnett NW. 1997. Regulatory mechanisms that modulate signaling by G-protein-coupled receptors. Biochem J 322:1-18.
7. 3 adenosine receptor. J Leuk Biol 66:495-501.
8. 3-adrenergic receptor is required for MAP kinase activation. J Biol Chem 275:38131-38134.
9. Chen L, Hahn H, Wu G, Chen C-H, Liron T, Schechtman D, Cavallaro G, Banci L, Guo Y, Bolli R, Dorn GW II, Mochly-Rosen D. 2001a. Opposing cardioprotective actions and parallel hypertrophic effects of δPKC and εPKC. Proc Natl Acad Sci USA 98:11114-11119.
10. Chen W, Hu LA, Semenov MV, Yanagawa S, Kikuchi A, Lefkowitz RJ, Miller WE. 2001b. β-arrestin1 modulates lymphoid enhancer factor transcriptional activity through interaction with phosphorylated dishevelled proteins. Proc Natl Acad Sci USA 98:14889-14894.
11. 1 adenosine receptors. Mol Pharmacol 52:778-797.
12. DeFea KA, Vaughn ZD, O'Bryan EM, Nishijima D, Dery O, Bunnett NW. 2000. The proliferative and antiapoptotic effects of substance P are facilitated by formation of a β-arrestin-dependent scaffolding complex. Proc Natl Acad Sci USA 97:11086-11091.
13. DeFea KA, Zalevsky J, Thoma MS, Dery O, Mullins RD, Bunnett NW. 2000. β-arrestin-dependent endocytosis of proteinaseactivated receptor 2 is required for intracellular targeting of activated ERK1/2. J Cell Biol 148:1267-1281.
14. 2A-adrenergic receptors confers subtype-specific agonist-promoted downregulation. Proc Natl Acad Sci USA 91:11178-11182.
15. 2A-adrenergic receptor. J Biol Chem 270:4681-4688.
16. Ferguson G, Watterson KR, Palmer TM. 2000. Subtype-specific kinetics of inhibitory adenosine receptor internalization are determined by sensitivity to phosphorylation by G-proteincoupled receptor kinases. Mol Pharmacol 57:546-552.
17. 3 adenosine receptors: consequences for agonist-stimulated translucation of arrestin 3. Biochemistry 41:14748-14761.
18. Ferguson SS, Caron MG. 1998. G protein-coupled receptor adaptation mechanisms. Semin Cell Dev Biol 9:119-127.
19. 1 adenosine receptor-G-protein complexes: effects of receptor downregulation and phosphorylation on coupling. Biochem J 338:729-736.
20. 1 adenosine receptor: enhanced proteolysis of palmitoylation-deficient mutant receptors. Biochem J 342:387-395.
21. 1 adenosine receptor and adenosine deaminase in an epithelial cell line. Mol Pharmacol 59:1314-1323.
22. 1 adenosine receptor agonist. J Biol Chem 265:5206-5210.
23. i downregulation as a mechanism for heterologous desensitization in adipocytes. J Biol Chem 267:3223-3229.
24. Gschwind A, Zwick E, Prenzel N, Leserer M, Ullrich A. 2001. Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission. Oncogene 20:1594-1600.
25. 2A receptors behave as an alternative anchoring protein for cell surface adenosine deaminase in lymphocytes and cultured cells. Mol Pharmacol 59:127-134.
26. Hoffmann BB, Chang H, Dall'Aglio E, Reaven GM. 1986. Desensitization of adenosine receptor-mediated inhibition of lipolysis: the mechanism involves the development of enhanced cyclic adenosine monophosphate accumulation in tolerant adipocytes. J Clin Invest 78:185-190.
27. phox. J Biol Chem 274:19731-19737.
28. Ji TH, Grossman M, Ji I. 1998. G protein-coupled receptors. I. Diversity of receptor-ligand interactions. J Biol Chem 273:17299-17302.
29. 3 adenosine receptors on human eosinophils elevates intracellular calcium. Blood 9:3569-3574.
30. Krupnick JG, Benovic JL. 1998. The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol 38:289-319.
31. 1 receptors translocate out of caveolae. J Biol Chem 275:4417-4421.
32. 3 receptor: sustained cardioprotection. Proc Natl Acad Sci U S A 95:6995-6999.
33. Linden J. 2001. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol 41:775-787.
34. 3 adenosine receptor with widespread tissue distribution. Mol Pharmacol 44:524-532.
35. Lohse MJ. 1993. Molecular mechanisms of membrane receptor desensitization. Biochim Biophys Acta 1179:171-188.
36. 2AR-bound palmitate and promotes receptor depalmitoylation. Biochemistry 35:15923-15932.
37. iα are not associated with changes in their mRNAs. Mol Pharmacol 36:681-688.
38. 2 adrenergic receptor-Src protein kinase complexes. Science 283:655-661.
39. McDonald PH, Chow CW, Miller WE, Laporte SA, Field ME, Lin F-T, Davis RJ, Lefkowitz RJ. 2000. β-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3. Science 290:1574-1577.
40. Miller WE, Lefkowitz RJ. 2001. Expanding roles for β-arrestins as scaffolds and adapters in GPCR signaling and trafficking. Curr Opin Cell Biol 13:139-145.
41. Mineo C, James GL, Smart EJ, Anderson RG. 1996. Localization of epidermal growth factor-stimulated Ras/Raf-1 interaction to caveolae membrane. J Biol Chem 271:11930-11935.
42. 2-adrenergic receptor by the cAMP-dependent protein kinase. J Biol Chem 271:21490-21497.
43. 2-adrenergic receptor regulates the synergistic action of cyclic AMP-dependent protein kinase and β-adrenergic receptor kinase involved in its phosphorylation and desensitization. J Neurochem 76:269-279.
44. 2-adrenergic receptor in Sf9 cells. J Biol Chem 267:21733-21737.
45. 2-adrenergic receptor: mutation of Cys341 in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptor. J Biol Chem 264:7564-7569.
46. 3 adenosine receptor. J Cell Physiol 186:19-23.
47. 3 adenosine receptor. Mol Pharmacol 45:978-982.
48. 3 adenosine receptors. J Biol Chem 269:24692-24698.
49. Olah ME, Stiles GL. 1995. Adenosine receptor subtypes: characterization and therapeutic regulation. Annu Rev Pharmacol Toxicol 35:581-606.
50. Oldenhof J, Vickery R, Anafi M, Oak J, Ray A, Schoots O, Pawson T, von Zastrow M, Van Tol HH. 1998. SH3 binding domains in the dopamine D4 receptor. Biochemistry 37:15726-15736.
51. Onorato JJ, Palczewski K, Regan JW, Caron MG, Lefkowitz RJ. Benovic, J.L. 1991. Role of acidic amino acids in peptide substrates of the β-adrenergic receptor kinase and rhodopsin kinase. Biochemistry 30:5118-5125.
52. 3 adenosine receptor: evidence for a G-protein-coupled receptor kinase-mediated mechanism. J Biol Chem 270:29607-29613.
53. 3 adenosine receptor. J Biol Chem 271:15272-15278.
54. 3 adenosine receptor. Mol Pharmacol 57:539-545.
55. i. J Biol Chem 262:841-847.
56. Pierce KL, Luttrell LM, Lefkowitz RJ. 2001. New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades. Oncogene 20:1532-1539:
57. Pierce KL, Maudsley S, Ahn S, Khan SD, Luttrell LM, Lefkowitz RJ. 2000. Role of endocytosis in the activation of the extracellular signal-regulated kinase cascade by sequestering and nonsequestering G protein-coupled receptors. Proc Natl Acad Sci USA 97:1489-1494.
58. Ping P, Zhang J, Pierce WM Jr, Bolli R. 2001. Functional proteomic analysis of protein kinase C epsilon signaling complexes in the normal heart and during cardioprotection. Circ Res 88:1306-1313.
59. Pizard A, Blaukat A, Michineau S, Dikic I, Muller-Esterl W, Alhenc-Gelas F, Rajerison RM. 2001. Palmitoylation of the human bradykinin B2 receptor influences ligand efficacy. Biochemistry 40:15743-15751.
60. 4A receptor is palmitoylated at two different sites, and acylation is critically involved in regulation of receptor constitutive activity. J Biol Chem 277:2534-25346.
61. Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, Ullrich A. 1999. EGF receptor transactivation by G-proteincoupled receptors requires metalloproteinase cleavage of proHBEGF. Nature 402:884-888.
62. Prossnitz ER, Kim CM, Benovic JL, Ye RD. 1995. Phosphorylation of the N-formyl peptide receptor carboxyl terminus by the G protein-coupled receptor kinase, GRK2. J Biol Chem 270:1130-1137.
63. 2-adenosine receptors in DDT1 MF-2 cells. Mol Pharmacol 40:639-647.
64. 3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells. J Biol Chem 268:16887-16890.
65. Rubino A, Yellon DM. 2000. Ischaemic preconditioning of the vasculature: an overlooked phenomenon for protecting the heart? Trends Pharmacol Sci 21:225-230.
66. 3 adenosine receptor. Proc Natl Acad Sci USA 90:10365-10369.
67. 1 adenosine receptors internalize together following agonist-induced receptor desensitization. J Biol Chem 273:17610-17617.
68. Shaul PW, Smart EJ, Robinson LJ, German Z, Yuhanna IS, Ying Y, Anderson RG, Michel T. 1996. Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem 271:6518-65122.
69. St Jules RS, O'Brien PJ. 1986. The acylation of rat rhodopsin in vitro and in vivo. Exp Eye Res 43:929-940.
70. 11α is not required for interaction with βγ complex. J Biol Chem 276:35883-35890.
71. Sudol M. 1998. From Src homology domains to other signaling modules: proposal of the 'protein recognition code'. Oncogene 17:1469-1474.
72. 3 adenosine receptors: role in receptor desensitization and resensitization. J Neurochem 75:1493-501.
73. 2-adrenergic receptor. J Biol Chem 274:31515-31523.
74. 3 adenosine receptor. Proc Natl Acad Sci USA 89:7432-7436.